Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC
Gj. Lyon et al., Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC, P NAS US, 97(24), 2000, pp. 13330-13335
Citations number
18
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Two-component signaling systems involving receptor-histidine kinases are ub
iquitous in bacteria and have been found in yeast and plants. These systems
provide the major means by which bacteria communicate with each other and
the outside world. Remarkably, very little is known concerning the extracel
lular ligands that presumably bind to receptor-histidine kinases to initiat
e signaling. The two-component agr signaling circuit in Staphylococcus aure
us is one system where the ligands are known in chemical detail, thus openi
ng the door for detailed structure-activity relationship studies. These lig
ands are short (8- to 9-aa) peptides containing a thiolactone structure, in
which the alpha -carboxyl group of the C-terminal amino acid is linked to
the sulfhydryl group of a cysteine, which is always the fifth amino acid fr
om the C terminus of the peptide. One unique aspect of the agr system is th
at peptides that activate virulence expression in one group of S. aureus st
rains also inhibit virulence expression in other groups of S. aureus strain
s. Herein, it is demonstrated by switching the receptor-histidine kinase, A
grC, between strains of different agr specificity types, that intragroup ac
tivation and intergroup inhibition are both mediated by the same group-spec
ific receptors. These results have facilitated the development of a global
inhibitor of virulence in S. aureus, which consists of a truncated version
of one of the naturally occurring thiolactone peptides.